Viewing StudyNCT01661868



Ignite Creation Date: 2024-05-06 @ 12:48 AM
Last Modification Date: 2024-10-26 @ 10:55 AM
Study NCT ID: NCT01661868
Status: WITHDRAWN
Last Update Posted: 2012-08-21
First Post: 2011-10-24

Brief Title: Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Ovarian Cancer
Peritoneal Cancer
Fallopian Tube Cancer
Keywords:
Name View
BRCA2 mutation View
BRCA1 mutation View